当前位置:首页 - 行情中心 - 华阳新材(600281) - 财务分析 - 现金流量表

华阳新材

(600281)

  

流通市值:24.90亿  总市值:24.90亿
流通股本:5.14亿   总股本:5.14亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金130,754,190.0973,530,238.26247,333,704.47136,503,614.84
  收到其他与经营活动有关的现金1,170,492.776,778,301.7712,004,105.7810,565,993.84
  经营活动现金流入小计131,924,682.8680,308,540.03259,337,810.25147,069,608.68
  购买商品、接受劳务支付的现金159,490,395.8468,876,229.9261,687,704.77177,246,816.96
  支付给职工以及为职工支付的现金26,090,998.7612,548,194.7547,368,681.8828,665,808.52
  支付的各项税费1,264,589.11400,942.68,900,598.338,221,223.2
  支付其他与经营活动有关的现金24,070,638.12,996,502.3226,693,501.4427,373,513.09
  经营活动现金流出小计210,916,621.8184,821,869.57344,650,486.42241,507,361.77
  经营活动产生的现金流量净额-78,991,938.95-4,513,329.54-85,312,676.17-94,437,753.09
二、投资活动产生的现金流量:
  处置固定资产、无形资产和其他长期资产收回的现金净额40,000,000-144,062,487.6771,294,128.24
  处置子公司及其他营业单位收到的现金净额1---
  投资活动现金流入的平衡项目0-00
  投资活动现金流入小计40,000,001-144,062,487.6771,294,128.24
  购建固定资产、无形资产和其他长期资产支付的现金897,40073,0004,469,643.033,409,221.46
  支付其他与投资活动有关的现金--69,786.41-
  投资活动现金流出小计897,40073,0004,539,429.443,409,221.46
  投资活动产生的现金流量净额39,102,601-73,000139,523,058.2367,884,906.78
三、筹资活动产生的现金流量:
  取得借款收到的现金106,890,572.894,441,352.8259,093,512.473,694,170
  收到其他与筹资活动有关的现金96,000,00046,000,000315,500,000109,500,000
  筹资活动现金流入小计202,890,572.8140,441,352.8574,593,512.4183,194,170
  偿还债务支付的现金100,337,00045,233,000319,460,00088,430,000
  分配股利、利润或偿付利息支付的现金9,918,560.724,981,459.9523,409,637.3917,625,063.73
  支付其他与筹资活动有关的现金52,549,969.8948,515,752.54298,873,458.9962,755,022.97
  筹资活动现金流出小计162,805,530.6198,730,212.49641,743,096.38168,810,086.7
  筹资活动产生的现金流量净额40,085,042.1941,711,140.31-67,149,583.9814,384,083.3
五、现金及现金等价物净增加额195,704.2437,124,810.77-12,939,201.92-12,168,763.01
  加:期初现金及现金等价物余额21,721,735.421,721,735.434,660,937.3234,660,937.32
  期末现金及现金等价物余额21,917,439.6458,846,546.1721,721,735.422,492,174.31
补充资料:
  净利润2,372,615.16--6,206,791.82-
  资产减值准备16,566,071.04-42,093,546.23-
  固定资产和投资性房地产折旧13,547,044.29-31,123,525.15-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧13,547,044.29-31,123,525.15-
  无形资产摊销252,530.04-505,060.08-
  长期待摊费用摊销1,153,595.88-2,457,763.2-
  处置固定资产、无形资产和其他长期资产的损失-38,329,837.98--126,200,337.66-
  固定资产报废损失--3,978.75-
  公允价值变动损失---30,897.1-
  财务费用9,940,823.2-23,983,995.95-
  投资损失--69,786.41-
  递延所得税534,007.61-7,782,928.23-
  其中:递延所得税资产减少1,397,156.11-8,055,631.79-
    递延所得税负债增加-863,148.5--272,703.56-
  存货的减少-38,132,428.51--56,027,214.67-
  经营性应收项目的减少-20,974,796.88-897,525.22-
  经营性应付项目的增加-30,525,473.76--15,001,891.57-
  不涉及现金收支的投资和筹资活动金额其他项目--8,852,688.13-
  现金的期末余额21,917,439.64-21,721,735.4-
  减:现金的期初余额21,721,735.4-34,660,937.32-
  现金及现金等价物的净增加额195,704.24--12,939,201.92-
公告日期2026-08-282026-04-302026-04-302025-10-29
审计意见(境内)标准无保留意见
TOP↑